JP2024525550A5 - - Google Patents

Info

Publication number
JP2024525550A5
JP2024525550A5 JP2024500184A JP2024500184A JP2024525550A5 JP 2024525550 A5 JP2024525550 A5 JP 2024525550A5 JP 2024500184 A JP2024500184 A JP 2024500184A JP 2024500184 A JP2024500184 A JP 2024500184A JP 2024525550 A5 JP2024525550 A5 JP 2024525550A5
Authority
JP
Japan
Prior art keywords
alkyl
carbonyl
chloro
amino
formate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024500184A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525550A (ja
JP7853400B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/068362 external-priority patent/WO2023280733A1/en
Publication of JP2024525550A publication Critical patent/JP2024525550A/ja
Publication of JP2024525550A5 publication Critical patent/JP2024525550A5/ja
Application granted granted Critical
Publication of JP7853400B2 publication Critical patent/JP7853400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024500184A 2021-07-06 2022-07-04 細菌感染症の処置のための第4級アンモニウムカチオン置換化合物 Active JP7853400B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/104682 2021-07-06
CN2021104682 2021-07-06
PCT/EP2022/068362 WO2023280733A1 (en) 2021-07-06 2022-07-04 Quaternary ammonium cation substituted compounds for the treatment of bacterial infections

Publications (3)

Publication Number Publication Date
JP2024525550A JP2024525550A (ja) 2024-07-12
JP2024525550A5 true JP2024525550A5 (cg-RX-API-DMAC7.html) 2025-10-08
JP7853400B2 JP7853400B2 (ja) 2026-04-28

Family

ID=82694189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500184A Active JP7853400B2 (ja) 2021-07-06 2022-07-04 細菌感染症の処置のための第4級アンモニウムカチオン置換化合物

Country Status (5)

Country Link
US (1) US20240376073A1 (cg-RX-API-DMAC7.html)
EP (1) EP4367102A1 (cg-RX-API-DMAC7.html)
JP (1) JP7853400B2 (cg-RX-API-DMAC7.html)
CN (1) CN117715892A (cg-RX-API-DMAC7.html)
WO (1) WO2023280733A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7846093B2 (ja) * 2020-09-07 2026-04-14 エフ. ホフマン-ラ ロシュ アーゲー 新規複素環式抗生物質
EP4370514A1 (en) 2021-07-15 2024-05-22 F. Hoffmann-La Roche AG Imidazole derivatives and their use as antibiotics
WO2026087442A1 (en) * 2024-10-22 2026-04-30 F. Hoffmann-La Roche Ag Amino-imidazole antibacterial compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016347456B2 (en) 2015-10-27 2018-12-13 F. Hoffmann-La Roche Ag Peptide macrocycles against acinetobacter baumannii
KR102434226B1 (ko) * 2016-06-30 2022-08-19 한미약품 주식회사 Alk5 억제제로서의 신규 피라졸 유도체 및 이의 용도
US11505573B2 (en) 2018-03-28 2022-11-22 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
JP2022513851A (ja) * 2018-12-17 2022-02-09 エフ.ホフマン-ラ ロシュ アーゲー 抗菌剤としてのイミダゾピラジン誘導体
TW202100522A (zh) * 2019-03-08 2021-01-01 瑞士商赫孚孟拉羅股份公司 新穎咪唑-吡唑衍生物
WO2021148420A1 (en) * 2020-01-22 2021-07-29 F. Hoffmann-La Roche Ag Novel heterocyclic compounds
CN115916784A (zh) * 2020-06-09 2023-04-04 豪夫迈·罗氏有限公司 新型咪唑并吡嗪衍生物
CN115989225A (zh) * 2020-08-31 2023-04-18 豪夫迈·罗氏有限公司 作为抗菌药物的咪唑-吡唑衍生物
JP7846093B2 (ja) * 2020-09-07 2026-04-14 エフ. ホフマン-ラ ロシュ アーゲー 新規複素環式抗生物質

Similar Documents

Publication Publication Date Title
JP2023510971A5 (cg-RX-API-DMAC7.html)
RU2378259C2 (ru) Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции
US7582659B2 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
JP2020193222A (ja) ピペリジニルインドール誘導体の新規な使用
US10173998B2 (en) Antifungal compound process
JP2007520520A5 (cg-RX-API-DMAC7.html)
JP2014511869A5 (cg-RX-API-DMAC7.html)
JP2022552655A5 (cg-RX-API-DMAC7.html)
JP7853400B2 (ja) 細菌感染症の処置のための第4級アンモニウムカチオン置換化合物
JP2010508338A5 (cg-RX-API-DMAC7.html)
JP2010508307A5 (cg-RX-API-DMAC7.html)
US9597314B2 (en) Beta-lactamylalkanoic acids for treating premenstrual disorders
JP2021514963A5 (cg-RX-API-DMAC7.html)
JP2013523814A5 (cg-RX-API-DMAC7.html)
JP2022543666A5 (cg-RX-API-DMAC7.html)
JP2024506182A5 (cg-RX-API-DMAC7.html)
US10464896B2 (en) Efflux-pump inhibitors and therapeutic uses thereof
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2022521380A5 (cg-RX-API-DMAC7.html)
JP2025506382A5 (cg-RX-API-DMAC7.html)
JP2018515489A5 (cg-RX-API-DMAC7.html)
JP2023547241A5 (cg-RX-API-DMAC7.html)
RU2006128445A (ru) Ацетилиновые пиперазиновые соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов
EP1654259A1 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
RU2014107536A (ru) Производное пирролидин-3-илуксусной кислоты